Corcept Therapeutics (CORT) EBIT Growth (3y) (2013 - 2026)
Corcept Therapeutics (CORT) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corcept Therapeutics | 9.56 Bn | 9.22 Bn | 162.02 Mn | -74.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.78% |
| Dec 31, 2025 | -41.58% |
| Sep 30, 2025 | -31.60% |
| Jun 30, 2025 | -5.32% |
| Mar 31, 2025 | -49.65% |
| Dec 31, 2024 | -11.68% |
| Sep 30, 2024 | 8.75% |
| Jun 30, 2024 | 3.67% |
| Mar 31, 2024 | 14.53% |
| Dec 31, 2023 | 1.25% |
| Sep 30, 2023 | 8.04% |
| Jun 30, 2023 | -5.69% |
| Mar 31, 2023 | -26.70% |
| Dec 31, 2022 | -13.71% |
| Sep 30, 2022 | -1.09% |
| Jun 30, 2022 | 8.46% |
| Mar 31, 2022 | 12.19% |
| Dec 31, 2021 | 13.77% |
| Sep 30, 2021 | 16.41% |
| Jun 30, 2021 | 15.68% |